Navigation Links
Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer
Date:8/30/2011

lity of life.  

Adding to this growing body of evidence for CyberKnife prostate SBRT is the completion of patient accrual in an Accuray sponsored, multi-center homogeneous prostate study for low and intermediate risk prostate cancer. The study is led by teams at the Swedish Cancer Center in Seattle and the Beth Israel Deaconess Medical Center in Boston and involves 21 centers in the US.  A total of 309 eligible patients have been accrued and are being followed closely to allow precise evaluation of the long term efficacy and toxicity outcomes following CyberKnife prostate SBRT.  

The benefits of CyberKnife SBRT for prostate cancer are well illustrated by the stories of the thousands of patients who have undergone treatment over the last eight years.  Dr. Michael Kendrick, a practicing physician familiar with radiosurgery, was the first patient in the world to undergo CyberKnife prostate SBRT and was treated in 2003 at Stanford.

"After learning about the CyberKnife and drawing on my expertise as a physician, deciding to move forward with CyberKnife prostate SBRT was a no brainer," said Dr. Michael Kendrick, one of the first CyberKnife patients. "CyberKnife's pinpoint accuracy and ability to track and correct for prostate motion was an important factor in my decision. I experienced no side effects, a fast recovery time, and was able to maintain a high quality of life during and following treatment. My PSA level has remained stable proving to me that CyberKnife SBRT was an effective treatment, a choice I have never regretted."

The CyberKnife System is a non-invasive treatment option for prostate cancer that has the ability to deliver targeted and destructive doses of radiation with the highest levels of accuracy enabling treatment of tumors close to critical, healthy structures. The CyberKnife System's unique ability to not only track, but also automatically correct for unpredictable movement of the prostate during treat
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
2. Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
3. Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500(TM)
4. Accuray Announces Regionalized Management Strategy for Americas
5. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
6. Accuray Introduces the CyberKnife(R) VSI(TM) System
7. Accuray Announces Results for Second Quarter Fiscal 2010
8. Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2010
9. Accuray Hires General Manager for Japan
10. Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference
11. Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 21, 2014   Rock Creek ... that the Company is scheduled to present at the ... Francisco, CA on January 12-14, 2015. ... and CEO of Rock Creek Pharmaceuticals, will present preclinical ... cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. Dr. Mullan ...
(Date:11/21/2014)... EVANSTON, Ill. , Nov. 21, 2014  Heated ... prescription drug prices – from cancer treatments to Gilead,s ... and pharmaceutical leaders around the world questioning what it ... quality of care. And while drug ... the pharmaceutical industry – from both a general business ...
(Date:11/21/2014)... , Nov. 21, 2014  PTC Therapeutics, Inc. (NASDAQ: ... 2014 Legend of Technology Award for Vision, Innovation, and Leadership ... Chief Executive Officer. This award recognizes an individual who has ... New Jersey for several decades. ... Award," stated Stuart Peltz , Ph.D., CEO of PTC ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
... Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS ... developer, manufacturer and seller of medicine and drugs ... announced that it plans to sell or transfer ... in the Chahaer Industrial Park, Inner Mongolia. Lotus, ...
... Inc. (OTC Bulletin Board: BHRT ) announced ... it finalized the formation of a working group. The ... clinical trial, combining a left ventricle assist device (LVAD) ... Bioheart,s MyoCath needle tipped catheter delivery system.   Initial ...
Cached Medicine Technology:Lotus Pharmaceuticals Announces Update on Land in Inner Mongolia 2Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 2Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 3Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 4Bioheart Announces Plans to Advance LVAD + Muscle Stem Cells Clinical Trial 5
(Date:11/22/2014)... York, New York (PRWEB) November 22, 2014 ... filed on behalf of patients who allegedly developed Type ... forward in the federal multidistrict litigation now underway in ... LLP reports. According to court documents, the litigation will ... 10:00 a.m. The Court has directed Lead Counsel for ...
(Date:11/22/2014)... Forbes Living TV and ... announce that Ashley Lombardo and friend Candy Sherman are ... Ms. Lombardo entered friend Candy Sherman to receive a ... how her friend is courageously battling lung cancer and ... Despite medical bills piling up and the constant struggle ...
(Date:11/22/2014)... November 22, 2014 Developers and plugin specialist ... plugin entitled FCPX 3D Model bringing the impossible to ... allows users to add obj files to FCPX enabling 3d ... “Blurring the line between professional and armature, FCPX 3D Model ... Film Studios allows Final Cut Pro X users to upload ...
(Date:11/22/2014)... -- A clinical trial of hydroxyurea therapy for children ... early because the results show it is a safe ... the risk of stroke. The announcement about the ... the United States and Canada, was made this week ... (NHLBI). Researchers compared monthly blood transfusions with daily ...
(Date:11/22/2014)... -- The widely used heart drug digoxin is associated ... who have the heart rhythm disorder atrial fibrillation but ... Atrial fibrillation is a common form of irregular ... risk for stroke among older Americans. Digoxin has been ... irregular heartbeat, the authors of the new study said, ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:Forbes Living TV Announces Winner of Thanksgiving #PayItForward Contest 2Health News:Pixel Film Studios released FCPX 3D Model plugin Exclusively for Final Cut Pro X 2Health News:Sickle Cell Anemia Treatment So Successful in Kids That Trial Is Halted 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 2Health News:Treating Irregular Heartbeat With Digoxin May Come With Risks 3
... Research Hospital scientists have rewritten the job description of ... brain cells from DNA damage. Such damage might foreshadow ... in the developing brain require TopBP1 to prevent DNA ... to cell division. Investigators also reported that stem cells ...
... MONDAY, April 23 (HealthDay News) -- Hispanic people with lung ... with the disease, according to a new study. Researchers ... genetic factors or environmental advantages, such as lower rates of ... and survival data on cancer patients from a national database ...
... colleagues in China have described a rapidly emerging ... plays a pivotal role in establishing methicillin-resistant S. ... author Michael Otto, Ph.D., of NIH,s National Institute of ... the molecular level how MRSA epidemics may emerge and ...
... cent increase in high blood pressure screening in 19 developing countries ... that occur each year by up to 3 per cent in ... of Cardiology are the first findings from a new report from ... The study found that around 900 million people in developing countries ...
... Patients are much more likely to develop small-bowel obstruction after ... than minimally invasive laparoscopic surgery, a new study finds. ... can develop within days of surgery as a result of ... admission to a hospital. In this study, Swedish researchers ...
... new studies analyzing treatment decisions in late-stage amyotrophic lateral ... extend the duration and quality of life in this ... of Medicine at the University of Pennsylvania found that ... resulted in not living long enough to experience the ...
Cached Medicine News:Health News:Protein prevents DNA damage in the developing brain and might serve as a tumor suppressor 2Health News:Protein prevents DNA damage in the developing brain and might serve as a tumor suppressor 3Health News:Hispanics Seem to Have Better Odds of Lung Cancer Survival 2Health News:NIH scientists link quickly spreading gene to Asian MRSA epidemic 2Health News:Lower Risk for Bowel Obstruction With Less Invasive Surgery: Study 2Health News:ALS patients differ on treatment choices in later phases of disease 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: